Srivastava Sonakshi, Ratho Radha Kanta, Singh Mini P, Sarkar Subhabrata, Pati Binod K
Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Department of Microbiology, Hind Institute of Medical Sciences, Barabanki, India.
Iran J Microbiol. 2024 Apr;16(2):243-250. doi: 10.18502/ijm.v16i2.15358.
The influenza A(H1N1) virus is known for large outbreaks, epidemics and pandemics worldwide owing to its genome plasticity which evolves constantly. In the year 2015 and then in 2017, India witnessed an upsurge in cases.
The study was carried out in this period (2015-2017) with samples from 5 states across north India. The hemagglutinin 1 (HA1) and non-structural 1 (NS1) gene segments of the viral genome were characterised by phylogenetic analysis, selection pressure analysis, prediction of potential glycosylation sites and phylodynamic analysis of the study strains.
The study strains belonged to genogroup 6B. A total of 12 mutations were observed, half of which were located on the key receptor binding region of the HA1 protein. Established virulence markers D222G, S183P were observed in 2017 samples. Acquisition of an extra glycosylation site was observed in few strains from 2017 and 2016. Selection pressure analysis found the average dN/dS (v) ratio of 0.2106 and few codon sites in particular showed significant evidence of being under negative selection.
The genogroup 6B continues to be the dominant circulating strain in Indian subcontinent region however the presence of pathogenic mutations in the 2017 strains from north India underlines the importance of continued molecular surveillance.
甲型H1N1流感病毒因其基因组可塑性不断进化,在全球引发了大规模暴发、流行和大流行。2015年及随后的2017年,印度病例数出现激增。
本研究在这一时期(2015 - 2017年)开展,采用了印度北部5个邦的样本。通过系统发育分析、选择压力分析、潜在糖基化位点预测以及对研究毒株的系统动力学分析,对病毒基因组的血凝素1(HA1)和非结构蛋白1(NS1)基因片段进行了特征描述。
研究毒株属于基因群6B。共观察到12个突变,其中一半位于HA1蛋白的关键受体结合区域。在2017年的样本中观察到了已确定的毒力标记D222G、S183P。在2017年和2016年的少数毒株中观察到获得了一个额外的糖基化位点。选择压力分析发现平均dN/dS(v)比率为0.2106,特别是少数密码子位点显示出明显的负选择证据。
基因群6B仍然是印度次大陆地区主要的流行毒株,然而,2017年印度北部毒株中致病突变的存在凸显了持续进行分子监测的重要性。